🧬 Health Futures #31

Happy Monday 👋

Major themes this week in health focused on the health workforce, AI in health, and pharmaceuticals. In the healthcare workforce, SSUHS signed an MOU agreement with Novo Nordisk to develop Assam’s health sector to improve nursing education. Smith & Nephew partners with HOPCo, aiming to improve patient care and outcomes in ambulatory surgery centers (ASCs). However, some regulatory concerns exist as the US FDA learned that a testing facility in India submitted fraudulent data for over 400 drugs, which the agency continues to prescribe and distribute instead of withdrawing from the market. In this week’s health funding, PayZen, an AI-powered health finance firm, stood out with its $232M Series B funding round.

🧑‍⚕️ Healthcare Training & Accreditation

🤝SSUHS partners with Novo Nordisk Foundation to boost nursing education. Srimanta Sankaradeva University of Health Sciences (SSUHS) signed an MoU with Novo Nordisk Foundation to enhance Assam's health sector, aiming to improve nursing education through an Education Innovation Unit, Simulation Lab, and financial support.

📚 NHA partners with MUHS for digital health education. The National Health Authority (NHA) and Maharashtra University of Health Sciences (MUHS) agreed to collaborate on digital health education programs to support the Ayushman Bharat Digital Mission.

👨‍⚕️ Alabama launched a new physician training program to address the doctor shortage. The Medical Association of the State of Alabama and the Alabama Board of Medical Examiners announced that applications are open for a groundbreaking initiative to address the state's physician shortage.

🤖 AI in Health

💉 SyMap's renal denervation system is approved in China. SyMap received China's National Medical Products Administration (NMPA) approval for its msRDN renal denervation system, which is classified as a Class III medical device.

🤝 Smith & Nephew partners with HOPCo for AI solutions in Ambulatory surgery centers. Smith & Nephew, an orthopedic and sports medicine company, partners with Healthcare Outcomes Performance Company (HOPCo) to collaborate on AI analytics and solutions for use in ambulatory surgery centers.

🤖 Caregility launched AI-powered fall risk detection for improved patient safety. Caregility, a telehealth solutions provider, introduced an AI-enabled fall risk detection feature in its iObserver application for continuous remote patient monitoring.

💉 Pharmaceuticals

⚠️ FDA failed to withdraw approval for hundreds of tainted drugs. The FDA inspected for its handling of fraudulent data from Indian testing facilities for over 400 drugs that are mostly classified as generic medicines. The FDA has allowed these drugs to remain in the market for further testing.

💊 Triastek and BioNTech collaborate on 3D-printed RNA therapeutics. Triastek, a company specializing in 3D printing pharmaceuticals, signed an agreement with BioNTech SE to research and develop 3D-printed oral RNA therapeutics.

📝 HealthLynked partners with RxSpark for better medication access. HealthLynked Corp. and RxSpark formed a partnership to integrate HealthLynked's healthcare network with RxSpark's pharmacy discounts and prescription price comparisons to improve medication access and management for patients.

💰 Deals of the Week

🤖 PayZen, a CA-based fintech technology company tackling healthcare affordability via AI-powered solutions, raised $232M in Series B funding. The company aims to use the funds for growth and market expansion.

🧫 Third Arc secured $165M oversubscribed Series A financing to advance the company through clinical studies to address significant unmet needs in oncology and autoimmunity.

🧬 Halda Therapeutics, a CT-based biotechnology company developing a novel class of cancer therapies called RIPTACTM (Regulated Induced Proximity Targeting Chimeras) therapeutics, raised $126M in Series B extension funding to advance two RIPTAC candidates into a clinical trial with prostate and breast cancer. 

🦵 Moximed, a medical device company aimed to improve the standard of care for people with knee osteoarthritis (OA), closed a $61M Series D financing with an option to close on up to an additional $30M.

💻 MD Ally, an NYC-based leader, closed a $14M Series A funding round, which is funds planned to use the funds to further enhance its 911 and EMS-integrated technology, expand clinical services, and extend downstream care coordination partnerships.

Thank you for reading. Have a great week ahead!
Have some feedback or suggestions? Let us know at hello@holoniq.com